Ovid Therapeutics Inc (OVID)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | OVID | AZN | AMGN | GILD | BMY |
| Company | Ovid Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 2.30 | 199.22 | 340.57 | 138.78 | 59.15 |
| High | 2.31 | 199.22 | 341.17 | 138.78 | 59.23 |
| Low | 2.29 | 197.95 | 336.83 | 137.50 | 58.44 |
| Latest | 2.32 | 198.25 | 336.41 | 137.85 | 58.05 |
| Change | +0.02 | -4.58 | -6.16 | -2.28 | -1.28 |
| % Change | +0.87% | -2.26% | -1.80% | -1.63% | -2.16% |
| Volume | 6,115 | 135,609 | 13,907 | 7,216 | 218,801 |
| 20-Day Average Volume | 4,647,666 | 1,756,490 | 2,521,275 | 5,838,726 | 13,058,681 |
| Previous Close | 2.30 | 202.83 | 342.57 | 140.13 | 59.33 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.24 | 192.01 | 354.98 | 140.62 | 59.17 |
| 20-Day Raw Stochastic | 50.30% | 71.09% | 0.88% | 25.11% | 34.63% |
| 20-Day Relative Strength | 58.60 | 54.22 | 37.65 | 45.16 | 48.00 |
| Weighted Alpha | +193.27 | +47.12 | +16.74 | +31.56 | +21.18 |
| Today's Opinion | 100% Buy | 88% Buy | 24% Buy | 40% Buy | 56% Buy |
| Previous Opinion | 100% Buy | 88% Buy | 24% Buy | 40% Buy | 100% Buy |
| Last Month's Opinion | 88% Buy | 80% Buy | 88% Buy | 88% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +9.24% since 03/30/26 | +2.27% since 03/30/26 | -3.38% since 03/30/26 | +1.06% since 03/30/26 | -2.14% since 03/30/26 |
| Low | 2.08 on 04/02/26 | 193.55 on 03/31/26 | 336.83 on 04/07/26 | 137.17 on 03/31/26 | 58.44 on 04/07/26 |
| High | 2.46 on 04/06/26 | 204.75 on 04/06/26 | 357.00 on 04/01/26 | 141.49 on 04/01/26 | 62.22 on 04/01/26 |
| 1-Month | |||||
| %Chg | +20.68% since 03/06/26 | +2.09% since 03/06/26 | -8.75% since 03/06/26 | -4.27% since 03/06/26 | -3.05% since 03/06/26 |
| Low | 1.82 on 03/09/26 | 182.39 on 03/24/26 | 336.83 on 04/07/26 | 133.89 on 03/30/26 | 56.45 on 03/24/26 |
| High | 2.72 on 03/20/26 | 204.75 on 04/06/26 | 380.14 on 03/11/26 | 149.38 on 03/10/26 | 62.22 on 04/01/26 |
| 3-Month | |||||
| %Chg | +29.49% since 01/07/26 | +4.19% since 01/07/26 | -1.30% since 01/07/26 | +10.80% since 01/07/26 | +3.05% since 01/07/26 |
| Low | 1.36 on 02/17/26 | 178.08 on 01/21/26 | 319.79 on 01/13/26 | 119.33 on 01/09/26 | 53.54 on 01/21/26 |
| High | 2.72 on 03/20/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +38.02% since 10/07/25 | +15.46% since 10/07/25 | +14.10% since 10/07/25 | +17.98% since 10/07/25 | +30.88% since 10/07/25 |
| Low | 1.18 on 11/14/25 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 42.52 on 10/29/25 |
| High | 2.72 on 03/20/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 303,313 | 314,570,656 | 184,668,512 | 173,932,464 | 121,136,144 |
| Shares Outstanding, K | 131,875 | 1,550,908 | 539,068 | 1,241,222 | 2,041,735 |
| Annual Sales | 7,250,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -17,410,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 720,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | 9,660,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | -0.03 | 0.35 | 0.47 | 0.39 | 0.27 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.06 on 03/18/26 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 05/12/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 22.22 | 15.92 | 17.14 | 9.69 |